Progenics Pharmaceuticals (PGNX)

Add to Watchlists
Create an Alert
3.57 +0.17  +5.00% NASDAQ Apr 16, 5:00PM BATS Real time Currency in USD
View Full Chart
PGNX Price Chart
View All Events

PGNX Events

Date Type Description
Mar 13 Misc Progenics Pharmaceuticals, Inc. Q4 2013 Earnings Conference Call
Mar 13 Earnings Progenics Pharmaceuticals, Inc. Q4 2013 Earnings Results. Estimate: -0.19.
Nov 11 Misc Progenics Pharmaceuticals Sets Third Quarter Financial Results Conference Call for November 11
Nov 11 Earnings Progenics Pharmaceuticals Sets Third Quarter Financial Results. Estimate: -0.21.
Aug 09 Misc Progenics Pharmaceuticals Second Quarter 2013 Results Conference Call
Aug 09 Earnings Progenics Pharmaceuticals Announces Second Quarter 2013 Financial Results. Estimate: -0.24.
Jul 18 Misc Progenics Pharmaceuticals Investor and Analyst Day
Jun 12 Misc AGM Event for Progenics Pharmaceuticals, Inc.
May 10 Misc Progenics Pharmaceuticals First Quarter 2013 Results Conference Call
May 10 Earnings Progenics Pharmaceuticals First Quarter 2013 Results Conference Call. Estimate: -0.19.
View All Performance Charts

PGNX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Progenics Pharmaceuticals is down 22.89% over the last year vs S&P 500 Total Return up 22.52%, Actelion up 73.54%, and Alexion Pharmaceuticals up 54.91%.

Get Quote for

Pro Strategies Featuring PGNX

Did Progenics Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

PGNX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Progenics Pharmaceuticals, Inc. develops and commercializes therapeutics for patients suffering from cancer and related conditions.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PGNX 3.57 +0.17 +5.00% 217.15M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.